● From a short-term investment perspective, the company presents a deteriorated fundamental situation


● The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.

● Analysts covering this company mostly recommend stock overweighting or purchase.


● The firm trades with high earnings multiples: 29.72 times its 2024 earnings per share.

● The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.

● For the past year, analysts have significantly revised downwards their profit estimates.

● For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.

● Over the past twelve months, analysts' opinions have been revised negatively.

● The company's earnings releases usually do not meet expectations.